Study Ensures Effective Ways To Measure Macular Pigment Density

(FT. LAUDERDALE, Fla., May 9, 1999) - Dietary lutein and zeaxanthin are the major determinants to explain macular pigment optical density (MPOD), according to research presented today at the Association for Research in Vision and Ophthalmology 1999 annual meeting. The study was the largest ever conducted to examine the relationship between dietary, medical, physical and lifestyle factors, and macular pigment density, thought to be protective in age-related macular degeneration (AMD).

"Results confirmed and expanded upon what's already known about the determinants of macular pigment density. Dietary lutein and zeaxanthin explained the greatest amount of macular pigment density variance, followed by serum lutein levels," said Thomas Ciulla, M.D., Retinal Specialist, Indiana University School of Medicine and Ophthalmology Department in Indianapolis, Ind.

Ciulla and his colleagues examined the MPOD of a cross sectional population of 280 healthy men and women in Indianapolis. They determined that dietary lutein and zeaxanthin, serum lutein and eye color are the factors most strongly associated with macular pigment density. Ciulla cautions, however, that, taken together, these factors explained only 19.7 % variance in MPOD.

Lutein and zeaxanthin are concentrated in retinal macular pigment and accumulation is thought to be dependent on dietary intake. Macular pigment may filter blue light that damages photoreceptors and the retinal pigment epithelium. In addition, carotenoids may limit oxidant stress resulting from metabolism and light, acting as antioxidants.

In this study, serum concentrations for lutein, zeaxanthin and beta-carotene were measured by HPLC, and MPOD was measured by heterochromatic flicker photometry. Dietary patterns and demographic/medical characteristics were determined by questionnaire. This method of study was a non-invasive way to measure MPOD and also showed that MPOD can be rel

Contact: Anne Tramer
Selz/Seabolt Communications

Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:

(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology:
Cached News: